Skip to Main Content

Author Details

Rafael Bejar
Moores Cancer Center, university of california san diego
2001
85
33
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36260702An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.Blood Adv2023
37808770IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromes.bioRxiv2023
37704469Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).Blood Rev2023
37552083Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.Blood Adv2023
36947201Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions.Blood Adv2023
37103953Newly revised 2023 MDS response criteria.Blood2023
36934059Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).Blood Rev2023
36053528Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.Blood Cancer Discov2022
35732831The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Leukemia2022
35368098Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.Hematol Oncol2022
35663282Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning.Leuk Res Rep2022
36517128How can we incorporate molecular data into the IPSS?Best Pract Res Clin Haematol2022
36517122How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms.Best Pract Res Clin Haematol2022
36335264Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.Leukemia2022
36206200RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS.Blood Adv2022
35931086DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.Immunity2022
36130297Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Blood2022
36266326Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.Leukemia2022
35926182Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.Blood Cancer Discov2022
33262074In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.Cytotherapy2021
33564192Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.Nat Med2021
33855780Indolent T-cell prolymphocytic leukemia with no expression of surface T-cell receptors or surface CD3.Int J Lab Hematol2021
34865696How do molecular aberrations guide therapy in MDS?Best Pract Res Clin Haematol2021
34283303Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.J Patient Rep Outcomes2021
331729745-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia Cells.Mol Cancer Res2021
33279399Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome.Cytotherapy2021
32347921SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.Blood2020
35847712Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease Registry.EJHaem2020
32026740Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.Leuk Lymphoma2020
31895053X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation.J Clin Invest2020
32044376Clonal hematopoiesis in cancer.Exp Hematol2020
32747829Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.Nat Med2020
30635634TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.Leukemia2019
31663066Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence.JCO Precis Oncol2019
31766023Advances in Personalized Therapeutic Approaches in Myelodysplastic Syndromes.J Natl Compr Canc Netw2019
30132795JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemia.Br J Haematol2019
31582393DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes.Blood Adv2019
31434702Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.Blood2019
31218454A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.J Patient Rep Outcomes2019
31111762The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.Leuk Lymphoma2019
30846499Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling.Haematologica2019
30403571Managing Clonal Hematopoiesis in Patients With Solid Tumors.J Clin Oncol2019
30670443MDS overlap disorders and diagnostic boundaries.Blood2019
29661788Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.Blood2018
29908887The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.J Mol Biol2018
30854305Clonal Hematopoiesis in Aging.Curr Stem Cell Rep2018
30583461Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.Cancers (Basel)2018
30466744What biologic factors predict for transformation to AML?Best Pract Res Clin Haematol2018
28040720Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2017
28373404Precancer Atlas to Drive Precision Prevention Trials.Cancer Res2017
  • 1 - 50 of 85

Recommended Authors

Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
Career Start Year 2015
Number of shared co-authors 1
Fiorella Schischlik
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 3
Anna Raimbault
CHU La Miletrie University Hospital Poitiers France.
Career Start Year 2012
Number of shared co-authors 6
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 8
Simone Feurstein
University Hospital Heidelberg
Career Start Year 2010
Number of shared co-authors 8
Tamara L Lamprecht
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 8
Kim-Hien T Dao
Astex Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 9
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 10
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 3
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 7
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 3
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 6
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 7
Naseema Gangat
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 10
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 10
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Career Start Year 2004
Number of shared co-authors 9
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 6
Sharon E Heath
Washington University School of Medicine.
Career Start Year 2003
Number of shared co-authors 8
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 2
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 4
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 8
Stephen T Oh
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 10
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 4
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 7
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 10
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 16
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 6
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 15
Mark J Routbort
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 11

Collaborators

David P Steensma
Novartis Institutes for BioMedical Research
Co-authored papers 18
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers 17
Benjamin L Ebert
Co-authored papers 17
Donna Neuberg
Co-authored papers 10
Matthew J Walter
Washington University School of Medicine in St. Louis
Co-authored papers 7
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 6
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers 6
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Uma Borate
The Ohio State University
Co-authored papers 5
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers 5
Robert Coleman Lindsley
Co-authored papers 5
Michael Heuser
Hannover Medical School
Co-authored papers 5
Luca Malcovati
University of Pavia & S. Matteo Hospital
Co-authored papers 5
Felicitas Thol
Hannover Medical School
Co-authored papers 5
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Co-authored papers 5
Ravindra Majeti
Stanford University School of Medicine
Co-authored papers 4
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
Lionel Ad??s
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 3
Anjana Rao
La Jolla Institute for Immunology
Co-authored papers 3
Christopher R Cogle
College of Medicine, University of Florida
Co-authored papers 3
Seishi Ogawa
Kyoto University
Co-authored papers 3
Dana E Rollison
Moffitt Cancer Center
Co-authored papers 3
Kelly L Bolton
Washington University School of Medicine
Co-authored papers 3
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Co-authored papers 3
Joop H Jansen
Co-authored papers 3
Petar Stojanov
Co-authored papers 2
Xiang-Dong Fu
Co-authored papers 2
Pablo Tamayo
University of California San Diego
Co-authored papers 2
Hui Wang
Co-authored papers 2
Release 1.2